Company: SINT
Filing Date: 2025-03-19
Form Type: S-3
Source: 0001493152-25-010936
Chunk: 2

Company: Sintx Technologies, Inc.
Filing Date: 2025-03-19
Form: S-3
Chunk 2
---
 to the offer and resale by the selling stockholders identified in this prospectus or their donees, pledgees, assignees, transferees, distributees or other successors-in-interest (the “selling stockholders”) of up to an aggregate of 3,007,271 shares (the “Shares”) of our common stock, par value $0.01 per share (the “common stock”), issued by us in connection with a private placement on February 20, 2025 consisting of (i) 1,171,189 shares of our common stock (the “PIPE Shares”), (ii) 278,098 shares of our common stock (the “Pre-Funded Warrant Shares”) issuable upon the exercise of pre-funded warrants to purchase shares of our common stock held by certain selling stockholders (the “Pre-Funded Warrants”), (iii) 1,449,287 shares of our common stock (the “Common Warrant Shares”) issuable upon the exercise of common warrants to purchase shares of our common stock held by selling stockholders (the “Common Warrants”), and (iv) placement agent warrants (the “Placement Agent Warrants” and together with the Common Warrants and Pre-Funded Warrants, the “Warrants”) to purchase an aggregate of up to 108,697 shares of common stock (the “Placement Agent Warrant Shares” and together with the Common Warrant Shares and Pre-Funded Warrant Shares, the “Warrant Shares”). The Shares and Warrants were issued to the selling stockholders in a private placement (the “Private Placement”) pursuant to a securities purchase agreement dated February 20, 2025.

We are not selling any shares of common stock under this prospectus and will not receive any proceeds from the sale by the selling stockholders of the Shares. We would, however, receive proceeds of up to approximately $5.28 million upon the exercise for cash of the Warrants held by the selling stockholders. Proceeds, if any, received from the exercise of such Warrants will be used for general corporate purposes and working capital. No assurances can be given that any Warrants will be exercised or that we will receive any cash proceeds upon such exercise if cashless exercise is available.

Sales of the Shares by the selling stockholders may occur at fixed prices, at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices. The selling stockholders may sell Shares from time to time to or through underwriters, broker